Hypericum extract versus imipramine or placebo in patients with moderate depression: Randomised multicentre study of treatment for eight weeks

British Medical Journal

Volumn 319, Issue 7224, 1999, Pages 1534-1538

  Philipp, Michael ^a   Kohnen, Ralf ^b   Hiller, Karl O ^c  

^a Bezirkskrankenhaus Landshut   (Germany)

^b IMEREM Inst Med Res Mgmt B   (Germany)

^c Steiner and Co   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERICUM EXTRACT; IMIPRAMINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GERMANY; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERICUM; IMIPRAMINE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHYTOTHERAPY; PLANTS, MEDICINAL; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0033547613     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. 1 Baldessarini RJ. Drugs and the treatment of psychiatric disorders: depression and mania. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. Goodman and Gilman's the pharmacological basis of therapeutis, 9th ed. New York: McGraw-Hill, 1996:431-59.
2. 2 Lépine JP, Gastpar M, Mendlewicz J, Tylee A on behalf of the Depression Research in European Society Steering Committee. Depression in the community: the first pan-European study DEPRES (depression research in European society). Int Clin Psychopharmacol 1997;12:19-29.
3. 3 Linden M, Maier W, Achberger M, Herr R, Helmchen H, Benkert O. Psychiatric diseases and their treatment in general practice in Germany. Results of a World Health Organization (WHO) study. Nervenarzt 1996;67:205-15.
4. 4 Linde K, Mulrow CD. St John's wort for depression. In: Cochrane Collaboration. Cochrane Library. Issue 2. Oxford: Update Software, 1999.
5. 5 De Smet PAGM, Nolen WA. St John's wort as an antidepressant. BMJ 1990;313:241-2.
6. 6 Volz HP. Controlled clinical trials of hypericum extracts in depressed patients - an overview, Pharmacopsychiat 1997;30(suppl);72-6.
7. 7 The European Commission. Adapted guideline from ICH-E9: note for guidance on statistical principles for clinical trials. London: European Agency for the Evaluation of Medicinal Products, 1998. [CPMP/ICH/363/96.]
8. 8 The European Commission. Adapted guideline from ICH-E6: note for guidance on good clinical practice. London: European Agency for the Evaluation of Medicinal Products, 1997. [CPMP/ICH/135/95.]
9. 9 The European Commission. Note for guidance: medicinal products for the treatment of depression. Brussels: Committee for Proprietary Medicinal Products, 1990.
10. 10 Lehmacher W. Aquivalenznachweise bei Multicenter-Studien. In; Michaelis J, Hommel G, Wellek S, eds. Europäische Perspektiven der Medizinischen Informatik, Biometrie und Epidemiologie. Munich: MMV Medizin Verlag, 1993:152-4.
11. 11 Montgomery SA. Clinically relevant effect sizes in depression. Eur Neuropsychopharmacol 1994;4:283-4.
12. 12 Röhmel J. Therapeutic equivalence investigations: statistical considerations. Statist Med 1998;17:1703-14.
13. 13 German Commission A. Monograph imipramine. Bundesanzeiger 1992, Aug 8.
14. 14 Bollini P, Pampallona S, Tibaldi G, Kupelnick B, Munizza C. Effectiveness of antidepressants: meta-analysis of dose-effect relationships in randomised clinical trials. Br J Pschiat 1999;174:297-303.
15. 15 Preskorn SH, Burke M. Somatic therapy for major depressive disorder: selection of an antidepressant. J Clin Psychiatry 1992;53(suppl):5-18.
16. 16 Heiligenstein JH, Ware JE Jr, Beusterien KM, Roback PJ, Andrejasich C, Tollefson GD. Acute effects of fluoxetine versus placebo on functional health and well-being in late-life depression. Int Psychogeriatr 1995;7(suppl):125-37.
17. 17 Ernst E, Rand JI, Barnes J, Stevinson C. Adverse effects profile of the herbal antidepressant St John's wort. Eur J Clin Pharmacol 1998;54:589-94.
18. 18 Angst J. A regular renew of the long-term follow-up of depression. BMJ 1997;315:1143-6.